ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-230 Cr | ₹321 Cr | ₹428 Cr | ₹300 Cr | ₹315 Cr |
What is the latest Net Current Assets ratio of ERIS LIFESCIENCES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-230 Cr |
Mar2023 | ₹321 Cr |
Mar2022 | ₹428 Cr |
Mar2021 | ₹300 Cr |
Mar2020 | ₹315 Cr |
How is Net Current Assets of ERIS LIFESCIENCES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-230 Cr | Negative | |
Mar2023 | ₹321 Cr | -24.83 | |
Mar2022 | ₹428 Cr | 42.51 | |
Mar2021 | ₹300 Cr | -4.70 | |
Mar2020 | ₹315 Cr | - |
Compare Net Current Assets of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹17,032.9 Cr | -11.1% | -3.2% | 45.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,102.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,137.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹118,974.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,112.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,991.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -11.1% |
-3.2% |
45.9% |
SENSEX | -1.7% |
-0.8% |
5.8% |
You may also like the below Video Courses